When Good Results Are Not Enough: How Expectations Move Growth Stocks

A company reports record revenue. Earnings exceed forecasts. Management raises its outlook for the year. The logical conclusion seems obvious: the stock should rise.

Sometimes it does. Sometimes it falls.

This apparent contradiction is one of the most important ideas for understanding growth stocks. Share prices respond not only to what a company has achieved, but also to what investors expected it to achieve. A strong business result can therefore become a disappointing market result if expectations were even higher.

Axon Enterprise offers a useful example of why this distinction matters. The company has delivered rapid growth across hardware, software and newer technology categories. For investors, however, the question is never simply whether Axon is growing. It is whether the company is growing fast enough to justify the expectations already embedded in its valuation.

Earnings Are Compared With a Number That Already Exists

Before a company publishes quarterly results, the market has already formed an opinion.

Analysts produce revenue and earnings estimates. Management may have issued guidance. Investors build their own assumptions about margins, customer demand and future growth. All of these expectations influence the share price before the earnings release arrives.

This creates an invisible benchmark.

Suppose a company increases quarterly revenue by 25%. Viewed in isolation, that might look excellent. But if investors expected 30%, the result represents a slowdown relative to what the market had priced in.

The opposite can happen as well. Revenue growth of 15% may appear modest, but if expectations were for 10%, investors suddenly have a reason to reconsider their forecasts upward.

The market is therefore constantly measuring reality against expectation, rather than reality against zero.

A Beat Is Only the Beginning

Axon's first quarter of 2026 illustrates how many layers can exist inside a single earnings report.

Revenue reached approximately $807 million, up 34% year over year and above the company's own expectations. Software & Services revenue increased 35%, while annual recurring revenue reached $1.5 billion. Management subsequently raised its full-year revenue growth outlook from 27–30% to 30–32%.

Those are strong numbers. Yet an investor still has more questions to ask.

Was the revenue beat driven by sustainable demand? What happened to margins? Is recurring revenue keeping pace? How much investment is required to support the next stage of expansion? And, perhaps most importantly, does the new guidance exceed what investors were already hoping to see?

This is why headlines such as “company beats estimates” rarely tell the entire story.

Guidance Can Matter More Than the Quarter

Financial results mostly describe what has already happened. Stock prices, by contrast, are concerned with what comes next.

That makes guidance particularly important for growth companies.

Imagine that a business reports an exceptional quarter but management signals slower growth ahead. Investors may immediately reduce estimates for future revenue and earnings. The historical result remains excellent, yet the valuation can change because expectations about the future have changed.

Axon's recent trajectory shows the other side of this mechanism. At the end of 2025, management initially projected 2026 revenue growth of 27–30%. Following Q1, it increased that range to 30–32%.

The important information was therefore not only that the latest quarter had been strong. Management was also telling investors that its expectations for the rest of the year had improved.

For a growth stock, that second message can be at least as important as the first.

The Faster a Company Grows, the Higher the Bar Can Become

Strong performance creates an unusual problem: success itself can raise expectations.

Axon entered 2026 after four consecutive years of annual revenue growth above 30%. The company also established a longer-term target of $6 billion in annual revenue and an adjusted EBITDA margin of approximately 28% by 2028.

A track record like this can make investors willing to assign substantial value to future growth. But it can also make the standard for future results increasingly demanding.

If the market begins assuming that rapid expansion will continue for years, simply delivering “good” growth may eventually stop being enough. Investors may want evidence that the company can maintain unusually high growth while improving profitability and converting expansion into cash flow.

This is one reason growth stocks can experience large price movements even when nothing appears fundamentally wrong with the underlying business.

The company may still be growing. The expectation attached to that growth has simply changed.

A Good Company and a Rising Stock Are Different Questions

Investors often combine two separate questions without realizing it.

The first is: Is this a strong business?

The second is: What performance does the current share price require from that business?

They are related, but they are not identical.

A company can gain customers, expand revenue and develop valuable products while its stock struggles because the market previously expected even more. Another company can face genuine challenges while its shares rise because investors had prepared for a worse outcome.

Understanding this distinction changes the way earnings season looks.

Revenue growth, margins and guidance still matter. But they gain meaning only when compared with the assumptions investors were using before the new information arrived.

For Axon and other fast-growing technology companies, that comparison can be particularly important. Strong growth attracts investors precisely because they expect more growth in the future. Each successful quarter therefore becomes both an achievement and a new benchmark.

On the stock market, good results answer one question. Whether they are good enough is an entirely different one.